(Q37785529)

23 August 2017

A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin (English)

1 reference

domain-ontology-based fuzzy-powered named-entity recognition matcher

23 August 2017

0 references

1 reference

1 reference

Pharmacology

5 February 2022

1 reference

Howard N Bockbrader

1

1 reference

23 August 2017

David Wesche

2

1 reference

23 August 2017

Raymond Miller

3

1 reference

23 August 2017

Sunny Chapel

4

1 reference

23 August 2017

Nancy Janiczek

5

1 reference

23 August 2017

Paula Burger

6

1 reference

23 August 2017

1 October 2010

1 reference

Clinical Pharmacokinetics

23 August 2017

1 reference

23 August 2017

49

1 reference

23 August 2017

10

1 reference

23 August 2017

661-669

1 reference

https://scigraph.springernature.com/pub.10.2165/11536200-000000000-00000

23 August 2017

0 references

cites work

Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission

1 reference

12 December 2020

Inter- and intra-subject variability in gabapentin absorption and absolute bioavailability

1 reference

12 December 2020

Antiepileptic drugs in the treatment of neuropathic pain

1 reference

12 December 2020

A microdialysis study on the mechanism of action of gabapentin

1 reference

12 December 2020

Mucosal uptake of gabapentin (neurontin) vs. pregabalin in the small intestine

1 reference

12 December 2020

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

1 reference

12 December 2020

Clinically relevant drug interactions with antiepileptic drugs

1 reference

12 December 2020

Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. The US Gabapentin Study Group No. 5

1 reference

12 December 2020

Selected CSF biochemistry and gabapentin concentrations in the CSF and plasma in patients with partial seizures after a single oral dose of gabapentin

1 reference

12 December 2020

Gabapentin Enhances the Analgesic Effect of Morphine in Healthy Volunteers

1 reference

12 December 2020

Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial

1 reference

12 December 2020

Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The International Gabapentin Study Group

1 reference

12 December 2020

Pharmacokinetics of pregabalin in subjects with various degrees of renal function

1 reference

12 December 2020

Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and the puerperium

1 reference

12 December 2020

The mechanisms of action of gabapentin and pregabalin

1 reference

12 December 2020

Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy

1 reference

12 December 2020

Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial

1 reference

12 December 2020

Structure-activity relationships of pregabalin and analogues that target the alpha(2)-delta protein.

1 reference

12 December 2020

Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy?

1 reference

12 December 2020

[3H]gabapentin may label a system-L-like neutral amino acid carrier in brain

1 reference

12 December 2020

Pharmacokinetics of gabapentin in subjects with various degrees of renal function

1 reference

12 December 2020

The absorption of gabapentin following high dose escalation

1 reference

12 December 2020

High dose gabapentin in refractory partial epilepsy: clinical observations in 50 patients

1 reference

12 December 2020

A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma

1 reference

12 December 2020

Effect of a high-protein meal on gabapentin pharmacokinetics.

1 reference

12 December 2020

The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel

1 reference

12 December 2020

Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin

1 reference

12 December 2020

Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery

1 reference

12 December 2020

Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.

1 reference

12 December 2020

Pharmacokinetics and metabolism of gabapentin in rat, dog and man.

1 reference

12 December 2020

Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures

1 reference

12 December 2020

Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study

1 reference

12 December 2020

Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures

1 reference

12 December 2020

Clinical pharmacokinetics of pregabalin in healthy volunteers

1 reference

12 December 2020

Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys

1 reference

12 December 2020

Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition

1 reference

12 December 2020

Mediation of highly concentrative uptake of pregabalin by L-type amino acid transport in Chinese hamster ovary and Caco-2 cells

1 reference

12 December 2020

Gabapentin in partial epilepsy. UK Gabapentin Study Group

1 reference

12 December 2020

Modulation of the in vivo effects of gabapentin by vigabatrin and SKF89976A.

1 reference

12 December 2020

10.2165/11536200-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

23 August 2017

0 references

1 reference